학술논문
Efficacy, safety, pharmacokinetic (PK) and pharmacodynamic (PD) data from phase I dose escalation of a novel therapeutic peptide, ST101, targeting the oncogenic transcription factor C/EBP beta, in patients (pts) with advanced and metastatic solid tumors
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041